OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
October 01, 2009
Dr Martin Cockcroft, Operations Manager at Tepnel Pharmaceutical Services, an established business of Gen-Probe Inc., speaks about harmonized microbiology methods.
Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more...
September 24, 2009
Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more...
The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs).
September 17, 2009
Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more...
September 10, 2009
Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...
September 03, 2009
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
September 02, 2009
Brief pharmaceutical news items for September 2009.
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
As new process validation guidelines emerge, industry needs to reinvent how it releases product.